綠通科技(301322.SZ):赫濤、拓弘投資擬分別以協議轉讓方式向匡小燁轉讓公司股份
格隆匯6月25日丨綠通科技(301322.SZ)公佈,股東赫濤、拓弘(珠海)創業投資企業(有限合夥)(簡稱“拓弘投資”)分別與赫濤的配偶匡小燁於2024年6月25日簽署《股份轉讓協議》,赫濤、拓弘投資擬分別以協議轉讓方式向匡小燁轉讓其直接持有的公司股份3,710,001股、4,255,335股,合計向匡小燁轉讓公司股份7,965,336股,佔公司總股本的5.43%,佔剔除公司最新披露的回購專用賬户中股份數量後總股本的5.44%。本次協議轉讓完成後,受讓方匡小燁六個月內不減持所受讓的公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.